EUVIMEDEUVIMED entdecken
Open Access

TO-207 Mitigates Radiation-Induced Hematopoietic Injury in a Murine Model of Lethal Total-Body Irradiation

Wanchang Cui iD, Lisa Hull, Asher Rothstein, Li Wang, Bin Lin, Min Zhai, Mang Xiao

Military Medicine · 2026

DOI: 10.1093/milmed/usag230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, 2026. Verfasst von Wanchang Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, United States. Hauptthemen laut MEDLINE: Whole-Body Irradiation, Acute Radiation Syndrome, Radiation-Protective Agents. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Radiation, National Institute of Allergy and Infectious Diseases, Opportunity Funds Management Core of the Centers for Medical Countermeasures, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ionizing radiation exposure can cause acute radiation syndrome (ARS) with life-threatening multi-organ damage. Although several hematopoietic growth factors are FDA-approved as radiation countermeasures, alternative strategies that target inflammatory mechanisms remain urgently needed. TO-207, formerly known as JTE-607, is a selective multi-cytokine inhibitor that suppresses pro-inflammatory cytokine secretion in human monocytes and macrophages. TO-207 represents a mechanistically distinct radiation mitigator; however, whether it suppresses the acute post-irradiation cytokine surge in vivo has not yet been directly demonstrated and remains to be confirmed in future studies. Materials and Methods Male CD2F1 mice were exposed to lethal total-body irradiation (TBI, 9.0 Gy, LD70/30). Mice received TO-207 (100 mg/kg, s.c.) or vehicle once daily for 3 consecutive days, starting at 24 hours after irradiation. Outcomes included 30-day survival, peripheral blood recovery, bone marrow clonogenic capacity, and serum cytokine profiling.

Results

TO-207 treatment improved survival to 65% compared to 45% in vehicle controls. Hematopoietic recovery was enhanced, with significant increases in colony-forming unit–granulocyte/macrophage (CFU-GM) and higher circulating monocyte counts on day 30. Serum cytokine profiling on day 30 revealed that 3 of 44 cytokines (G-CSF, KC, TNF-α) showed nominally significant differences between groups; however, none remained significant after Benjamini–Hochberg correction for multiple comparisons. These day-30 cytokine observations are exploratory and reflect patterns of altered immune reconstitution rather than direct evidence of acute cytokine suppression.

Conclusions

TO-207 significantly mitigated hematopoietic injury and improved survival when administered 24 hours after lethal irradiation. These findings highlight TO-207 as a promising candidate for development as a medical countermeasure for ARS. Future studies incorporating early cytokine time points, dose optimization, and both sexes are needed to substantiate the mechanistic hypothesis and maximize translational impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Whole-Body IrradiationAcute Radiation SyndromeRadiation-Protective AgentsAnimalsMiceMaleCytokinesDisease Models, Animal

Substanzen

CytokinesRadiation-Protective Agents

Autor:innen und Institutionen

  • Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, United States.

ORCID-Profile: Wanchang Cui

Förderung

  • Radiation, National Institute of Allergy and Infectious Diseases
  • Opportunity Funds Management Core of the Centers for Medical Countermeasures
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • AFRRI

Zitieren

APA

Cui, W., Hull, L., Rothstein, A., Wang, L., Lin, B., Zhai, M., & Xiao, M. (2026). TO-207 Mitigates Radiation-Induced Hematopoietic Injury in a Murine Model of Lethal Total-Body Irradiation. Military Medicine. https://doi.org/10.1093/milmed/usag230

Vancouver

Cui W, Hull L, Rothstein A, Wang L, Lin B, Zhai M, et al. TO-207 Mitigates Radiation-Induced Hematopoietic Injury in a Murine Model of Lethal Total-Body Irradiation. Military Medicine. 2026. doi:10.1093/milmed/usag230

BibTeX
@article{Cui2026,
  author = {Cui, Wanchang and Hull, Lisa and Rothstein, Asher and Wang, Li and Lin, Bin and Zhai, Min and Xiao, Mang},
  title = {TO-207 Mitigates Radiation-Induced Hematopoietic Injury in a Murine Model of Lethal Total-Body Irradiation},
  journal = {Military Medicine},
  year = {2026},
  doi = {10.1093/milmed/usag230}
}
Kostenlos starten →